NextPlat Corp. (NASDAQ:NXPL) Sees Large Decline in Short Interest

NextPlat Corp. (NASDAQ:NXPL) was the target of a large decrease in short interest during the month of May. As of May 31st, there was short interest totalling 332,400 shares, a decrease of 26.1% from the May 15th total of 449,800 shares. Currently, 2.4% of the company’s shares are short sold. Based on an average daily volume of 210,300 shares, the short-interest ratio is currently 1.6 days.

Institutional Trading of NextPlat

An institutional investor recently bought a new position in NextPlat stock. Renaissance Technologies LLC acquired a new position in shares of NextPlat Corp. (NASDAQ:NXPL) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 28,000 shares of the company’s stock, valued at approximately $30,000. Renaissance Technologies LLC owned about 0.11% of NextPlat as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 1.30% of the company’s stock.

NextPlat Price Performance

NXPL stock opened at $0.68 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.62 and a quick ratio of 3.08. The firm has a market capitalization of $17.73 million, a P/E ratio of -1.05 and a beta of 0.89. The business’s 50-day moving average is $0.60 and its two-hundred day moving average is $0.87. NextPlat has a 1 year low of $0.43 and a 1 year high of $2.30.

NextPlat (NASDAQ:NXPL) last released its quarterly earnings data on Thursday, May 15th. The company reported ($0.05) EPS for the quarter. NextPlat had a negative net margin of 22.21% and a negative return on equity of 13.76%. The business had revenue of $14.53 million during the quarter.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.